Latest Breaking News On - Benign prostatic hyperplasia - Page 5 : comparemela.com

EEP using thulium fiber laser equally effective as high-power holmium laser in large prostates in terms of complications: Study

Singapore: A recent real-world study published in Prostate International reaffirmed that high-power holmium laser (HPHL) thulium fiber laser (TFL) in large prostates is equally efficacious concerning.

Prostate internationalDepartment of urologySingapore general hospitalProstate endoscopic enucleationNdoscopic enucleation of the prostateLaser therapyProstatic hyperplasiaPostoperative complicationsUrinary incontinenceThulium fiber laserHolmium laserLarge prostateBenign prostatic hyperplasia

Earnings decline continues for Olympus

The CEO of Olympus anticipates some negative revenue impact on fiscal 2024 results and as yet uncalculated impact on fiscal 2025.

Center valleyNew yorkUnited statesLake successLehigh countyStefan kaufmanCholangio pancreatographyTherapeutic solutions businessOlympus corporationVeran medical technologies incTherapeutic solutionsOlympus corporation of the americasOlympus terumo biomaterials corporationOlympus groupEndoscopic solutionsEndoscopic solutions business

2024 AUA Data Research Program Awardees Announced

BALTIMORE, Feb. 13, 2024 (GLOBE NEWSWIRE) The American Urological Association (AUA) is pleased to select six research teams as recipients of the 2024.

United statesKevin michael wymerSusanne quallichKevin kooChristian pavlovichMichael rezaeeEmily huangCandace granbergAaron potretzkeMichelle van kuikenMitchell humphreysGina badalatoKathleen kobashiData research programIntegration of technologyAmerican urological association

Lipocine Announces Continued Commercialization Of TLANDO® Through Verity Pharmaceuticals

Lipocine Announces Continued Commercialization Of TLANDO® Through Verity Pharmaceuticals
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesLipocine incPrnewswire lipocine incDrug administrationGordon silverCentral nervous systemVerity pharmaGordon silver limitedBoxed warningProduct labelBlood pressureBenign prostatic hyperplasiaPotential riskProstate cancerSerum testosterone concentrationsAdverse effects

Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals

SALT LAKE CITY, Feb. 2, 2024 /PRNewswire/ Lipocine Inc. , a biopharmaceutical company focused on treating Central Nervous System disorders, today announced that commercialization of TLANDO® in.

United statesLipocine incPrnewswire lipocine incGordon silverDrug administrationCentral nervous systemVerity pharmaGordon silver limitedBoxed warningProduct labelBlood pressureBenign prostatic hyperplasiaPotential riskProstate cancerSerum testosterone concentrationsAdverse effects